As a part of its corporate philanthropy policy piloted by the BNP Paribas Foundation, CIB (Corporate & Investment Banking) has chosen to continue its partnership with the Institut Pasteur for the third year running.
The entity’s support comes in the form of financial aid to medical research teams that are a part of the Institut Pasteur International Network in some 20 countries, as well as to laboratories that work with the Pasteur Institute of Paris.
More than €1.3 million has been earmarked for research into infectious diseases and vaccinations for measles and HIV (France), hepatitis C (Japan, Spain), malaria (Brazil), tuberculosis (Netherlands), polio (Russia), dengue fever (Hong Kong) etc.
This partnership has a true international dimension, and the projects supported in each of these countries are characterized by innovation and quality. It’s with great pride that CIB continues to support this prestigious institution.